choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • OncoMed Pharmaceuticals IPO

OncoMed Pharmaceuticals IPO Newsletter
  • IPO Update: Nkarta Proposes Terms For $150 Million IPO 05 Jul 2020 16:41 GMT

    … , CEO and Chairman of OncoMed Pharmaceuticals (OMED) and held similar … liabilities. (Unaudited, interim) IPO Details NKTX intends to sell … . Listed underwriters of the IPO are Cowen, Evercore ISI, … .S. IPOs with IPO Edge research. Members of IPO Edge get …

  • Nkarta Begins U.S. IPO Rollout 22 Jun 2020 22:14 GMT

    … , CEO and Chairman of OncoMed Pharmaceuticals (OMED) and held similar … liabilities. (Unaudited, interim) IPO Details Nkarta intends to raise … . Listed bookrunners of the IPO are Cowen, Evercore ISI, … .S. IPOs with IPO Edge research. Members of IPO Edge get …

  • U.S. IPO Weekly Recap: Lyft And Pinterest Edge Closer To IPO 23 Feb 2019 14:17 GMT

    … Nasdaq by merging with OncoMed. 3 Filings During the … insurance industry. IPO Market Snapshot The Renaissance IPO Indices are … Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, … Capital's International IPO ETF (NYSE: IPOS) tracks the index, …

  • IPOs, M&A, and Dividends: Taking A Look At Year-End News Catalysts 14 Dec 2018 20:35 GMT

    … of 2018. Tencent Music’s IPO Chinese conglomerate Tencent Holding ADR … (OTC: TCEHY) finally held its IPO for its music streaming service … Mereo As was previously reported, Oncomed Pharmaceuticals Inc. (NASDAQ: OMED) and rare …

  • OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma 05 Dec 2018 21:52 GMT

    Xconomy San Francisco —  OncoMed Pharmaceuticals attracted hundreds of … . Founded in 2004, OncoMed focused on developing antibody … . Prior to its 2013 IPO, OncoMed had raised $325 million … with pharmaceutical companies. When OncoMed went public, it raised …

  • The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs 15 Oct 2018 07:10 GMT

    … data for AGEN2034 (cervical cancer) Oncomed Pharmaceuticals Inc (NASDAQ: OMED) – Phase … )(after the market close) IPOs LogicBio Therapeutics, a pre- … million shares in an IPO, with an estimated price … the ticker symbol SIBN. IPO Quiet Period Expiry Elanco …

  • The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More 07 May 2018 00:46 GMT

    … ) Ocular Therapeutix Inc (NASDAQ: OCUL) Oncomed Pharmaceuticals Inc (NASDAQ: OMED) Prothena Corporation … ) Fibrocell Science Inc (NASDAQ: FCSC) IPO Immuno-oncology company Abpro is …

  • Busy Year Ahead For OMED, There's HOPE For GBT, APLS Sinks Below IPO Price 13 Dec 2017 03:33 GMT

    The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector. 1. OncoMed Pharmaceuticals Inc. (OMED) Lost 15.52% to close Tuesday's (Dec.12) trading at $3.92. News: No news Clinical trials & …

  • OncoMed Pharmaceuticals: Is This $4.50 Busted IPO A Buy? 29 Sep 2017 20:42 GMT

    … $150 million, shares of OncoMed Pharmaceuticals (OMED) have lost three … development and commercialization while Oncomed would stand to receive … Celgene and one-third by OncoMed. Profits in the United … time follower to the Busted IPO Forum by clicking here, …

  • Newman Ferrara LLP : Announces Corporate Governance Investigation of OncoMed Pharmaceuticals Inc. 16 May 2017 01:09 GMT

    … on behalf of shareholders of OncoMed Pharmaceuticals Inc. (“OncoMed” or the “Company”) ( … lackluster performance since its 2013 initial public offering, it is clear that the … s direction and leadership. Current OncoMed stockholders seeking more information on …

Satisfied with the content?

Continue to create your account.